이정연 (한양대학교 의과대학)님 | 한빛사연구자 > 한빛사

한양대학교 의과대학

최종업데이트 2025.09.07.

Improving HER2 Diagnostics with Digital Real-Time PCR for Ultrafast, Precise Prediction of Anti-HER2 Therapy Response in Patients with Breast Cancer
- Small Methods, Sep 06 2025, | https://doi.org/10.1002/smtd.202500599
- 2025-09
- 의약학
- 한빛사논문
Ultrasensitive and Rapid Circulating Tumor DNA Liquid Biopsy Using Surface-Confined Gene Amplification on Dispersible Magnetic Nano-Electrodes
- ACS Nano, May 11 2024, | https://doi.org/10.1021/acsnano.3c12266
- 2024-05
- 바이오·의료융합
- 한빛사논문
Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer
- JNCI-J. Natl. Cancer Inst., Published: 27 September 2018 | https://doi.org/10.1093/jnci/djy151
- 2018-09
- 의약학
- 한빛사논문
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
- JNCI-J. Natl. Cancer Inst., Volume 110, Issue 4, 1 April 2018, djx207 | https://doi.org/10.1093/jnci/djx207
- 2017-10
- 의약학
- 한빛사논문
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
- Nat. Commun., Published 22 July 2015 | doi:10.1038/ncomms8821
- 2015-07
- 의약학
- 한빛사논문
MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence
- J. Clin. Invest., 2015;125(5):1801–1814. | doi:10.1172/JCI73743
- 2015-03
- 의약학
- 한빛사논문

연구자 ID

저자논문